Funded by Eurostars, the Obtain project incorporates the cutting-edge Laprixa tissue viability assessment technology into an 8mm probe, enhanced with a steerable head for improved surgical accessibility. In this pre-clinical in vivo test, blood pressure measurements were successfully taken, and the mechanical components performed flawlessly.

The next phase involves transitioning the prototype into a robust, manufacturable device, led by engineer Jason Millenaar in collaboration with injection molding specialists Samaplast. Additionally, software engineer Pim Nijdam, in partnership with Dynatron, is updating the Laprixa module and software to enable measurement of multiple soft tissues with greater accuracy.

This milestone signifies a major advancement in surgical technology, promising to offer surgeons a superior tool for predicting wound healing capacity of tissue during surgery. Corporis Medical continues to innovate, pushing the boundaries of medical technology.